Aiqun Xue

427 total citations
16 papers, 339 citations indexed

About

Aiqun Xue is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Aiqun Xue has authored 16 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Aiqun Xue's work include Pancreatic and Hepatic Oncology Research (7 papers), Protease and Inhibitor Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). Aiqun Xue is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Protease and Inhibitor Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). Aiqun Xue collaborates with scholars based in Australia. Aiqun Xue's co-authors include Ross C. Smith, Thomas J. Hugh, Christopher J. Scarlett, Jaswinder S. Samra, Chris Jackson, Anthony J. Gill, Robert C. Baxter, Matthew H. Wong, Nick Pavlakis and Kai Brown and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Cancer Letters.

In The Last Decade

Aiqun Xue

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiqun Xue Australia 11 173 135 124 40 39 16 339
Anna Tyutyunnykova Germany 3 180 1.0× 198 1.5× 122 1.0× 38 0.9× 16 0.4× 4 336
Malek Kreidieh Lebanon 6 166 1.0× 170 1.3× 110 0.9× 57 1.4× 33 0.8× 13 376
Sunsook Hwang South Korea 10 91 0.5× 187 1.4× 169 1.4× 41 1.0× 20 0.5× 15 367
Clifford C. Nwaeburu Germany 8 218 1.3× 272 2.0× 196 1.6× 40 1.0× 36 0.9× 9 473
Zheng Su China 10 210 1.2× 215 1.6× 91 0.7× 30 0.8× 32 0.8× 25 452
Jelena Urosevic Spain 8 227 1.3× 221 1.6× 111 0.9× 72 1.8× 37 0.9× 10 462
Shaoyong Peng China 13 159 0.9× 193 1.4× 161 1.3× 64 1.6× 82 2.1× 24 437
Yanbo Zheng China 11 86 0.5× 169 1.3× 69 0.6× 56 1.4× 28 0.7× 40 308
Ulrike Maegdefrau Germany 6 94 0.5× 330 2.4× 238 1.9× 49 1.2× 36 0.9× 9 579

Countries citing papers authored by Aiqun Xue

Since Specialization
Citations

This map shows the geographic impact of Aiqun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiqun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiqun Xue more than expected).

Fields of papers citing papers by Aiqun Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiqun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiqun Xue. The network helps show where Aiqun Xue may publish in the future.

Co-authorship network of co-authors of Aiqun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Aiqun Xue. A scholar is included among the top collaborators of Aiqun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiqun Xue. Aiqun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brown, Kai, Aiqun Xue, Ross C. Smith, et al.. (2021). Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases. Cancer Medicine. 11(2). 492–506. 7 indexed citations
2.
Xue, Aiqun, Xiaojuan Gong, Sohel M. Julovi, et al.. (2020). Biomimetic Gemcitabine–Lipid Prodrug Nanoparticles for Pancreatic Cancer. ChemPlusChem. 85(6). 1283–1291. 17 indexed citations
3.
Smith, Ross C., Anthony J. Gill, Kerry‐Anne Rye, et al.. (2020). Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice. Cancer Letters. 495. 112–122. 7 indexed citations
4.
Nahm, Christopher B., et al.. (2019). SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort. Journal of Surgical Research. 238. 127–136. 9 indexed citations
5.
Brown, Kai, Aiqun Xue, Sohel M. Julovi, et al.. (2018). Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity. Journal of Surgical Research. 227. 158–167. 9 indexed citations
6.
Brown, Kai, Aiqun Xue, Anubhav Mittal, et al.. (2016). Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review. Oncotarget. 7(40). 66212–66225. 48 indexed citations
7.
Julovi, Sohel M., Aiqun Xue, Anthony J. Gill, et al.. (2016). Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo. PLoS ONE. 11(3). e0151475–e0151475. 19 indexed citations
8.
Wong, Matthew H., Aiqun Xue, Robert C. Baxter, Nick Pavlakis, & Ross C. Smith. (2016). Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma. Neoplasia. 18(7). 425–435. 33 indexed citations
9.
Xue, Aiqun, Sohel M. Julovi, Thomas J. Hugh, et al.. (2015). A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas. Pancreatology. 15(4). 397–404. 9 indexed citations
10.
Wong, Matthew H., Aiqun Xue, Sohel M. Julovi, et al.. (2014). Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 20(15). 4047–4058. 33 indexed citations
11.
Xue, Aiqun, et al.. (2012). Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS. Pancreatology. 12(2). 124–129. 10 indexed citations
12.
Xue, Aiqun, Meilang Xue, Chris Jackson, & Ross C. Smith. (2009). Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. The International Journal of Biochemistry & Cell Biology. 41(8-9). 1731–1738. 29 indexed citations
13.
Xue, Aiqun, Christopher J. Scarlett, Chris Jackson, Barry Allen, & Ross C. Smith. (2008). Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal Adenocarcinoma. Pancreas. 36(2). 160–167. 50 indexed citations
14.
15.
Scarlett, Christopher J., Jaswinder S. Samra, Aiqun Xue, Robert C. Baxter, & Ross C. Smith. (2007). CLASSIFICATION OF PANCREATIC CYSTIC LESIONS USING SELDI‐TOF MASS SPECTROMETRY. ANZ Journal of Surgery. 77(8). 648–653. 14 indexed citations
16.
Smith, Ross C., Aiqun Xue, Anthony J. Gill, et al.. (2007). High Expression of Plasminogen Activator Inhibitor‐2 (PAI‐2) is a Predictor of Improved Survival in Patients with Pancreatic Adenocarcinoma. World Journal of Surgery. 31(3). 493–502. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Tyutyunnykova Breakdown of academic impact, for papers by Malek Kreidieh Breakdown of academic impact, for papers by Sunsook Hwang Breakdown of academic impact, for papers by Clifford C. Nwaeburu Breakdown of academic impact, for papers by Zheng Su Breakdown of academic impact, for papers by Jelena Urosevic Breakdown of academic impact, for papers by Shaoyong Peng Breakdown of academic impact, for papers by Yanbo Zheng Breakdown of academic impact, for papers by Ulrike Maegdefrau
Rankless by CCL
2026